In particular, plectin’s cancer-specific cell surface mislocalization has revealed plectin expression as a biomarker or prognostic indicator in several cancers, including pancreatic, ovarian, lung, prostate, and head and neck cancer [10,11,13,14,15,16,17]. Here, PLEC is linked to head and neck cancer.